Promising ETA selective antagonist after ABT-627/ABT-546.

被引：0
|
作者：
Jai, HS [1 ]
Winn, M [1 ]
Chiou, WJ [1 ]
Nguyen, B [1 ]
Marsh, KC [1 ]
von Geldern, TW [1 ]
机构：
[1] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 221卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
57-MEDI
引用
收藏
页码：U10 / U10
页数：1
相关论文
共 46 条
  • [1] Preparation of endothelin antagonist ABT-627
    Wittenberger, SJ
    McLaughlin, MA
    TETRAHEDRON LETTERS, 1999, 40 (40) : 7175 - 7178
  • [2] Pharmacokinetics and pharmacodynamic effects of ABT-627, an oral ETA selective endothelin antagonist, in humans
    Verhaar, MC
    Grahn, AY
    van Weerdt, AWM
    Honing, MLH
    Morrison, PJ
    Yang, YHP
    Padley, RJ
    Rabelink, TJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 (06) : 562 - 573
  • [3] Selective ETA receptor antagonism with ABT-627 attenuates all renal effects of endothelin in humans
    Honing, MLH
    Hijmering, ML
    Ballard, DE
    Yang, YHP
    Padley, RJ
    Morrison, PJ
    Rabelink, TJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2000, 11 (08): : 1498 - 1504
  • [4] Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621:: in vitro studies
    Wu-Wong, JR
    Dixon, DB
    Chiou, WJ
    Sorensen, BK
    Liu, G
    Jae, HS
    Tasker, A
    von Geldern, TW
    Winn, M
    Opgenorth, TJ
    CLINICAL SCIENCE, 2002, 103 : 107S - 111S
  • [5] ABT-627, an endothelin ETA receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain
    Jarvis, MF
    Wessale, JL
    Zhu, CZ
    Lynch, JJ
    Dayton, BD
    Calzadilla, SV
    Padley, RJ
    Opgenorth, TJ
    Kowaluk, EA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 388 (01) : 29 - 35
  • [6] Development of a catalytic, asymmetric michael addition in the synthesis of the endothelin antagonist ABT-546.
    Barnes, DM
    Ji, JG
    Zhang, J
    King, SA
    Wittenberger, SJ
    Morton, HE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U61 - U61
  • [7] Effects of a selective ETA-receptor antagonist, atrasentan (ABT-627), in murine models of allergic asthma:: demonstration of mouse strain specificity
    Gosselin, M
    Goulet, S
    Wu-Wong, JYR
    Wessale, JL
    Opgennorth, TJ
    Boulet, LP
    Battistini, B
    CLINICAL SCIENCE, 2002, 103 : 367S - 370S
  • [8] Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621:: ex vivo and in vivo studies
    Wessale, JL
    Adler, AL
    Novosad, EI
    Calzadilla, SV
    Dayton, BD
    Marsh, KC
    Winn, M
    Jae, HS
    von Geldern, TW
    Opgenorth, TJ
    Wu-Wong, JR
    CLINICAL SCIENCE, 2002, 103 : 112S - 117S
  • [9] ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro
    Salani, D
    Rosanò, L
    Di Castro, V
    Spinella, F
    Venuti, A
    Padley, RJ
    Nicotra, MR
    Natali, PG
    Bagnato, A
    CLINICAL SCIENCE, 2002, 103 : 318S - 321S
  • [10] Effect of ABT-627 (A-147627), a potent selective ETA receptor antagonist, on the cardiopulmonary profile of newborn lambs with surgically-induced diaphragmatic hernia
    Kavanagh, M
    Battistini, B
    Jean, S
    Crochetière, J
    Fournier, L
    Wessale, J
    Opgenorth, TJ
    Cloutier, R
    Major, D
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (08) : 1679 - 1688
12345